Filarial disease in the Brazilian Amazon and emerging opportunities for treatment and control

Following the successful eradication of Wuchereria bancrofti, there are now just three species of conventional microfilaremic human filarial parasites endemic to the Brazilian Amazon region: Mansonella ozzardi, Mansonella perstans and Onchocerca volvulus. The zoonotic filarial parasite Dirofilaria i...

Full description

Saved in:
Bibliographic Details
Published in:Current research in parasitology & vector-borne diseases Vol. 5; p. 100168
Main Authors: Portela, Cleudecir Siqueira, Mendes de Araújo, Cláudia Patrícia, Moura Sousa, Patrícia, Gomes Simão, Carla Letícia, Silva de Oliveira, João Carlos, Crainey, James Lee
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 2024
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Following the successful eradication of Wuchereria bancrofti, there are now just three species of conventional microfilaremic human filarial parasites endemic to the Brazilian Amazon region: Mansonella ozzardi, Mansonella perstans and Onchocerca volvulus. The zoonotic filarial parasite Dirofilaria immitis is also found in the Amazon region as are several sylvatic filarial parasites, some of which have been recorded causing zoonoses and some of which have never been recorded outside the region. Onchocerca volvulus is only found in the Amazonia onchocerciasis focus in the Brazilian state of Roraima where it affects the people of the Yanomami tribe living around the densely forested Venezuela border region. Mansonella ozzardi is by far the most common filarial parasite in Brazil and has a broad but patchy distribution throughout the western Amazon region. Recorded in the Brazilian states of Acre, Roraima, Matto Grosso, and within almost every municipality of Amazonas state, it is believed that pollution of the urban stream and river systems prevents the development of the simuliid vectors of M. ozzardi and explains the parasiteʼs reduced distribution within urban areas and an absence of recent reports from the state capital Manaus. Decades of WHO-led periodic ivermectin treatment of Yanomami tribeʼs people have resulted in the partial suppression of O. volvulus transmission in this focus and has also probably affected the transmission of M. ozzardi in the region. Mansonella perstans, O. volvulus and very probably M. ozzardi infections can all be treated and most likely cured with a 4–6-week treatment course of doxycycline. The Brazilian Ministry of Health does not, however, presently recommend any treatment for mansonellosis infections and thus parasitic infections outside the Amazonia focus are typically left untreated. While the long treatment courses required for doxycycline-based mansonellosis therapies preclude their use in control programmes, new fast-acting filarial drug treatments are likely to soon become available for the treatment of both onchocerciasis and mansonellosis in the Amazon region. Filarial disease management in the Brazilian Amazon is thus likely to become dramatically more viable at a time when the public health importance of these diseases is increasingly being recognized. [Display omitted] •Following W. bancrofti elimination, the Brazilian Amazon remains endemic to O. volvulus, M. ozzardi and M. perstans.•Sylvatic filarial parasites in the Amazon region are likely causing an increasing number of undetected zoonoses.•Onchocerciasis is the only filarial disease currently being targeted for control in the Brazilian Amazon.•Despite the lack of a known disease burden, interest in the treatment and control Amazonian mansonellosis is growing.•Emerging filarial disease treatments may radically change disease control options in the Brazilian Amazon and beyond.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:2667-114X
2667-114X
DOI:10.1016/j.crpvbd.2023.100168